Cartesian Therapeutics, Inc. Operating Leases, Future Minimum Payments, Due in Four Years
Cartesian Therapeutics, Inc. (RNAC) had Operating Leases, Future Minimum Payments, Due in Four Years of $335.00 thousand as of 2016-12-31, per its 10-Q filed 2017-11-07.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears · last filed 2017-11-07
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $335.00K.
- 2015-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $1.33M.
| Period end | Operating Leases, Future Minimum Payments, Due in Four Years |
|---|---|
| 2016-12-31 | $335.00K 10-Q · filed 2017-11-07 |
| 2015-12-31 | $1.33M 10-Q · filed 2016-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |